Development, acceptability, appropriateness and appeal of a cancer clinical trials implementation intervention for rural- and minority-serving urology practices
Authors:
- Shellie EllisSEShellie Ellis
- Mugur GeanaMGMugur Geana
- Tomas GrieblingTGTomas Griebling
- Charles McWilliamsCMCharles McWilliams
- Jessie GillsJGJessie Gills
- Kelly StrattonKSKelly Stratton
- Christine MackayCMChristine Mackay
- Ariel ShifterASAriel Shifter
- Andrew ZganjarAZAndrew Zganjar
- Brantley ThrasherBTBrantley Thrasher
Open Access
- 7 October 2019
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 20 (1) , 1-13
Abstract
Background: Few community urologists offer cancer patients the opportunity to participate in cancer clinical trials, despite national guidelines that recommend it, depriving an estimated 260,000 urological cancer patients of guideline-concordant care each year. Existing strategies to increase urologists’ offer of clinical trials are designed for resource-rich environments and are not feasible for many community urologists. We sought to design an implementation intervention for dissemination in under-resourced community urology practices and to compare its acceptability, appropriateness and adoption appeal among trial-naïve and trial-experienced urologists.Methods: We used a design-for-dissemination approach, informed by the Theoretical Domains Framework and Behavior Change Wheel, to match determinants of the clinical trial offer to theoretically informed implementation strategies. We described the implementation intervention in evaluation workshops offered at urology professional society meetings. We surveyed participants to assess the implementation intervention’s acceptability and appropriateness using validated instruments. We also measured adoption appeal, intention to adopt and previous trial offer.Results: Our design process resulted in a multi-modal implementation intervention, comprised of multiple implementation strategies designed to address six domains from the Theoretical Domains Framework. Evaluation workshops delivered at four meetings, convened five separate professional societies. Sixty-one percent of those offered an opportunity to participate in the implementation intervention indicated intention to adopt. Average implementation intervention acceptability and appropriateness ratings were 4.4 and 4.4 (out of 5), respectively. Acceptability scores were statistically significantly higher among those offering trials compared to those not (p = 0.03). Appropriateness scores did not differ between those offering trials and those not (p = 0.24). After urologists ranked their top three innovation attributes, 43% of urologists included practice reputation in their top three reasons for offering clinical trials; 30% listed practice differentiation among their top three reasons. No statistically significant differences were found between those who offered trials and those who did not among any of the innovation attributes.Conclusions: LEARN|INFORM|RECRUIT is a promising implementation intervention to address low accrual to clinical trials, poised for implementation and effectiveness testing. The implementation intervention is appealing to its target audience and may have equal uptake among trial-naïve and trial-experienced practices.Keywords
Funding Information
- National Cancer Institute (R25 CA171994)
- Brown Foundation (No number)
This publication has 50 references indexed in Scilit:
- Validation of the theoretical domains framework for use in behaviour change and implementation researchImplementation Science, 2012
- Engaging Referring Physicians in the Clinical Trial ProcessJournal of Oncology Practice, 2012
- Sustainability and performance of the National Cancer Institute's Community Clinical Oncology ProgramContemporary Clinical Trials, 2012
- The Prevalence and Economic Impact of Low-Enrolling Clinical Studies at an Academic Medical CenterAcademic Medicine, 2011
- The behaviour change wheel: A new method for characterising and designing behaviour change interventionsImplementation Science, 2011
- A Population-Based Assessment of Specialty Physician Involvement in Cancer Clinical TrialsJNCI: Journal of the National Cancer Institute, 2011
- Accrual Experience of National Cancer Institute Cooperative Group Phase III Trials Activated From 2000 to 2007Journal of Clinical Oncology, 2010
- Designing for diffusion: How can we increase uptake of cancer communication innovations?Patient Education and Counseling, 2010
- Multidisciplinary Care in the Oncology Setting: Historical Perspective and Data From Lung and Gynecology Multidisciplinary ClinicsJournal of Oncology Practice, 2010
- Oncologists’ recommendations of clinical trial participation to patientsPatient Education and Counseling, 2008